CME Group Inc.
CME
$307.85
-$2.86-0.92%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.54B | 1.43B | 1.59B | 1.53B | 1.41B |
| Total Other Revenue | 108.40M | 104.00M | 102.60M | 107.60M | 108.80M |
| Total Revenue | 1.64B | 1.53B | 1.69B | 1.64B | 1.52B |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.64B | 1.53B | 1.69B | 1.64B | 1.52B |
| SG&A Expenses | 473.10M | 440.00M | 430.30M | 407.30M | 417.00M |
| Depreciation & Amortization | 82.40M | 82.60M | 83.40M | 82.50M | 83.40M |
| Other Operating Expenses | 39.60M | 39.20M | 45.70M | 41.60M | 70.00M |
| Total Operating Expenses | 595.10M | 561.80M | 559.40M | 531.40M | 570.40M |
| Operating Income | 1.05B | 972.60M | 1.13B | 1.11B | 952.30M |
| Income Before Tax | 1.58B | 1.18B | 1.33B | 1.24B | 1.10B |
| Income Tax Expenses | 395.50M | 269.00M | 305.20M | 288.60M | 222.00M |
| Earnings from Continuing Operations | 1.18B | 908.00M | 1.03B | 956.20M | 874.60M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.18B | 908.00M | 1.03B | 956.20M | 874.60M |
| EBIT | 1.05B | 972.60M | 1.13B | 1.11B | 952.30M |
| EBITDA | 1.13B | 1.06B | 1.21B | 1.19B | 1.04B |
| EPS Basic | 3.25 | 2.49 | 2.81 | 2.63 | 2.40 |
| Normalized Basic EPS | 2.71 | 2.05 | 2.31 | 2.16 | 1.89 |
| EPS Diluted | 3.24 | 2.49 | 2.81 | 2.62 | 2.40 |
| Normalized Diluted EPS | 2.71 | 2.04 | 2.31 | 2.16 | 1.89 |
| Average Basic Shares Outstanding | 359.63M | 359.69M | 359.66M | 359.61M | 359.57M |
| Average Diluted Shares Outstanding | 360.23M | 360.42M | 360.36M | 360.23M | 360.05M |
| Dividend Per Share | 1.25 | 1.25 | 1.25 | 1.25 | 1.15 |
| Payout Ratio | 38.46% | 50.14% | 44.42% | 268.50% | 47.88% |